All In MedTech

Device Trial Radar · NCT01811446

Evaluation of Muscle Activation Efficiency in Challenging Subjects

Evaluation of Muscle Stimulation Efficiency in Challenging Subjects: A Pilot Study

Last checked: Nov 20, 2026Latest source record: Jan 31, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Mar 2013

Primary completion

Sep 2013

Sponsor

Lead sponsor
Niveus Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 14, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether muscle activation can be accomplished more effectively and comfortably in challenging subjects using novel configurations of an activation device. A novel device will be compared side by side with a market leading device.

Conditions

  • Obesity
  • COPD

Interventions

  • Muscle Activation with Niveus and Intelect DevicesDevice

    Subjects will receive muscle activation technology from the Niveus device on one leg and from the Intelect (commercially-available third-party) device on the other. The order of use and the leg applied to will be randomized.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Intensity RequiredTime frame: During treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Fogarty Clinical Research

    Mountain View, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.